Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Farge

Showing results (121-130 of 192) with videos related to

Pageof 20
Sort By:
Oncotarget|June 23, 2018
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)Dominique Farge, Francis Cajfinger, Nicolas Falvo, et al.
Current Research in Translational Medicine|January 3, 2022
COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune diseaseTamim Alsuliman, Nicolas Stocker, Zoé Van de Wyngaert, et al.
Frontiers in Immunology|August 31, 2018
Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With SclerodermaJulie Di Cristofaro, Karlin R Karlmark, Sami B Kanaan, et al.
Frontiers in Immunology|July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working PartiesRaffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
Bone Marrow Transplantation|April 24, 2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)Charlotte Laurent, Zora Marjanovic, Laure Ricard, et al.
Cytotherapy|August 19, 2025
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseasesLindsay C Davies, Lucie Biard, Damián García-Olmo, et al.
Bone Marrow Transplantation|April 20, 2018
Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosisLucas C M Arruda, João R Lima-Júnior, Emmanuel Clave, et al.
Cytotherapy|May 14, 2026
Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trialInés Colmegna, Marie Hudson, Lucie Biard, et al.
Bulletin Du Cancer|July 17, 2021
[Autologous hematopoietic cells for severe autoimmune diseases: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) for immune monitoring and biobanking]Pauline Lansiaux, Séverine Loisel, Cristina Castilla-Llorente, et al.
Frontiers in Cell and Developmental Biology|July 22, 2022
Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A ReviewRyad Tamouza, Fernanda Volt, Jean-Romain Richard, et al.
Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
Oncotarget|June 23, 2018
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)Dominique Farge, Francis Cajfinger, Nicolas Falvo, et al.
Current Research in Translational Medicine|January 3, 2022
COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune diseaseTamim Alsuliman, Nicolas Stocker, Zoé Van de Wyngaert, et al.
Frontiers in Immunology|August 31, 2018
Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With SclerodermaJulie Di Cristofaro, Karlin R Karlmark, Sami B Kanaan, et al.
Frontiers in Immunology|July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working PartiesRaffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
Bone Marrow Transplantation|April 24, 2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)Charlotte Laurent, Zora Marjanovic, Laure Ricard, et al.
Cytotherapy|August 19, 2025
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseasesLindsay C Davies, Lucie Biard, Damián García-Olmo, et al.
Bone Marrow Transplantation|April 20, 2018
Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosisLucas C M Arruda, João R Lima-Júnior, Emmanuel Clave, et al.
Cytotherapy|May 14, 2026
Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trialInés Colmegna, Marie Hudson, Lucie Biard, et al.
Bulletin Du Cancer|July 17, 2021
[Autologous hematopoietic cells for severe autoimmune diseases: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) for immune monitoring and biobanking]Pauline Lansiaux, Séverine Loisel, Cristina Castilla-Llorente, et al.
Frontiers in Cell and Developmental Biology|July 22, 2022
Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A ReviewRyad Tamouza, Fernanda Volt, Jean-Romain Richard, et al.
Pageof 20